Dosage and dosing regimen of recombinant DNA-derived coagulation factor VIII concentrate (recombinant)

Recombinant DNA-derived factor VIII concentrate (Altuiiio) is a highly effective injectable medication designed to control and reduce the number of bleeding episodes in patients with hemophilia type A (congenital factor VIII deficiency). When using Altuiiio for treatment, the appropriate dosage and usage need to be determined based on the specific situation and the advice of your doctor.

When used as needed to treat and control bleeding episodes, The recommended dose of Altuiiiio is a single injection of 50 IU/kg. Depending on the patient's specific condition, an additional dose of 30 or 50 IU/kg over 2 to 3 days may also be considered if necessary to ensure effective control of bleeding. This flexible medication plan allows doctors to adjust medication frequency and dosage according to patients' actual needs to better respond to sudden bleeding events.

In perioperative management,Altuiiio is also administered as a single injection of 50 IU/kg. Before surgery, doctors will determine whether additional doses need to be continued after surgery based on the patient's bleeding risk assessment. As with on-demand treatment, perioperative management may also consider the use of additional doses of 30 or 50 IU/kg within the next 2 to 3 days to ensure that the patient's bleeding risk is effectively controlled throughout the entire surgical procedure and postoperative recovery period.

Altuiiio's dose selection takes into account the patient's weight and condition to ensure adequate clotting factors are provided while minimizing the risk of side effects. When using this drug, patients should follow the doctor's instructions and regularly monitor the treatment effect and any possible side effects to ensure the safety and effectiveness of the treatment.

In short,Altuiiio is a coagulation factor replacement therapy for hemophilia A. Its flexible dosage regimen meets the treatment needs of patients in different situations, and provides an important guarantee for improving the quality of life of hemophilia patients. During the treatment process, maintaining good communication with the doctor and providing timely feedback on medication effects and related reactions are the keys to ensuring successful treatment.

Reference link: https://www.rxlist.com/altuviiio-drug.htm